Literature DB >> 10811509

MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

G Toffoli, A Veronesi, M Boiocchi, D Crivellari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10811509     DOI： 10.1023/a:1008337900349

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  12 in total

Review 1.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

2.  Looking for the right drug for the right patient: a tale of old drugs and new pathways.

Authors:  Emilio Alba; Nuria Ribelles
Journal:  Clin Transl Oncol       Date:  2005-10       Impact factor: 3.405

Review 3.  Pharmacogenetics in inflammatory bowel disease.

Authors:  Marie Pierik; Paul Rutgeerts; Robert Vlietinck; Severine Vermeire
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

4.  Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.

Authors:  Lin Yang; Xin Hu; Luhang Xu
Journal:  Tumour Biol       Date:  2012-04-20

5.  Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease.

Authors:  Gabriele Stocco; Stefano Martelossi; Franca Sartor; Giuseppe Toffoli; Paolo Lionetti; Arrigo Barabino; Massimo Fontana; Giuliana Decorti; Fiora Bartoli; Tullio Giraldi; Alessandro Ventura
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

6.  Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.

Authors:  Kyoko Sugimoto; Makoto Murata; Makoto Onizuka; Yoshihiro Inamoto; Seitaro Terakura; Yachiyo Kuwatsuka; Taku Oba; Koichi Miyamura; Yoshihisa Kodera; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-03-26       Impact factor: 2.490

Review 7.  One-carbon metabolism and breast cancer: an epidemiological perspective.

Authors:  Xinran Xu; Jia Chen
Journal:  J Genet Genomics       Date:  2009-04       Impact factor: 4.275

8.  Fatal methotrexate toxicity: could it have been avoided?

Authors:  Reva Tripathi; Preeta Kaur Chugh; Deepa Kaur Chugh; Vertika Verma; Y M Mala
Journal:  BMJ Case Rep       Date:  2013-06-12

9.  Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.

Authors:  Y Berkun; D Levartovsky; A Rubinow; H Orbach; S Aamar; T Grenader; I Abou Atta; D Mevorach; G Friedman; A Ben-Yehuda
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 10.  Pharmacogenetics and pharmacogenomics in rheumatology.

Authors:  Zoltán Szekanecz; Bertalan Meskó; Szilard Poliska; Andrea Váncsa; Szilvia Szamosi; Edit Végh; Enikö Simkovics; Judit Laki; Júlia Kurkó; Timea Besenyei; Katalin Mikecz; Tibor T Glant; László Nagy
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.